Compare JTAI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JTAI | BMRA |
|---|---|---|
| Founded | 2018 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 8.2M |
| IPO Year | N/A | N/A |
| Metric | JTAI | BMRA |
|---|---|---|
| Price | $1.44 | $2.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 101.5K | 21.5K |
| Earning Date | 11-14-2025 | 01-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,584,279.00 | $4,884,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $433.36 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.40 | $2.08 |
| 52 Week High | $11.77 | $10.16 |
| Indicator | JTAI | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 31.89 | 57.12 |
| Support Level | $1.55 | $2.43 |
| Resistance Level | $1.69 | $2.67 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 5.87 | 84.46 |
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.